Remarkably, CRISPR-Gold corrected 5.4% of the mutated dystrophin gene in mdx mice (a transgenic mouse model for Duchenne muscular dystrophy) and restored protein expression in muscles, which renders it a very promising therapeutic approach for Duchenne muscular dystrophy treatment [27]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.